← FDA Drug Approvals (Drugs@FDA)

GABAPENTIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: INVAGEN PHARMS · Approved 2009-12-30

Drug application

FDA Application #

ANDA090705

Application type

Abbreviated New Drug Application (Generic)

Brand name

GABAPENTIN

Generic name

GABAPENTIN

Active ingredients

GABAPENTIN

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

INVAGEN PHARMS

Manufacturer

Exelan Pharmaceuticals, Inc.

First approval

2009-12-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown